Patient P-02280

Synthetic patientMETA-24 · Day 124 · 25–34 · F · baseline S07Steering view · 3D Open companion preview

Therapy response

Declining

Tolerance

Deteriorating

GI state

Favorable

Inflammatory state

Deteriorating

Nutritional resilience

Favorable

Discontinuation risk

13%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S07
Day 108 BR-03 recommended — Behavioural Recommendation BR-03
Day 109 Patient accepted — Started BR-03 in the companion
Day 116 No meaningful change — Behavioural Recommendation BR-03

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Toxicity+9
Inflammatory activity+5
Nutritional resilience-2
Treatment adherence+2

What helped?

Behavioural Recommendation BR-03Day 108
Result: no meaningful change

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

66 min

stable · +0.9 vs previous 14 d

Sleep duration

Wearable

5.8 h

stable · -0.0 vs previous 14 d

Energy level

Daily log

5.7/10

worsening · -0.6 vs previous 14 d

Steps

Wearable

6,226

stable · +3 vs previous 14 d

GI burden

Companion

21.5/100

stable · -0.6 vs previous 14 d

Adherence

Companion

98.7 %

stable · +3.3 vs previous 14 d

Sleep quality

Wearable

35.8/100

worsening · -1.8 vs previous 14 d

Glucose, CGM daily mean

CGM

127 mg/dL

stable · +0.4 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 66 from the failing basin, 29 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -6.1 next day on high-intake days · n 20

Would not help

BR-03 Behavioural Recommendation
already tried, no meaningful change

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-6.1supporter · 95%
Alcohol
-2.4no signal · 51%
Histamine load
-2no signal · 43%
Ultra-processed food
-1.9no signal · 33%
Caffeine
+1.7no signal · 37%
Insoluble fibre
+1.1no signal · 24%
Dietary fat load
-0.9no signal · 17%
Simple carbohydrates
-0.9no signal · 18%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Autonomic recovery ↓45
- WearableResting HR 73 bpm
- WearableShort sleep window
Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion
Mucosal barrier integrity ↓10
- WearableSleep 5.8 h, below personal baseline

DNA

Fictional pharmacogenomic panel

CYP2D6 Intermediate metabolizer
Expected exposure
GLP1R rs6923761 A
Altered receptor sensitivity

Microbiome

Shannon diversity 4.4 · butyrate capacity 82/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumLow
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 60 ms
Sleep: 6.0 h
Steps: 6,375
Resting HR: 71 bpm

Daily log: GI score 22, nutritional resilience 62, adherence 99.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02285	34%	S14	AD-05	no change	39
P-02031	33%	S12	AD-05	improved	47
P-02267	42%	S09	BR-03	no change	45
P-02638	37%	S01	BR-03	improved	41
P-02087	36%	S01	BR-03	no change	40
P-02483	33%	S06	BR-03	no change	64
P-02235	38%	S14	DT-01	improved	50
P-02685	38%	S16	DT-01	improved	47
P-02274	36%	S15	DT-01	improved	50
P-02479	36%	S13	DT-01	improved	48
P-02491	36%	S09	DT-01	no change	65
P-02339	35%	S03	DT-01	improved	50